Evaluation of non-modified wireframe DNA origami for acute toxicity and biodistribution in mice.

Abstract

Wireframe DNA origami can be used to fabricate virus-like particles for a range of biomedical applications, including the delivery of nucleic acid therapeutics. However, the acute toxicity and biodistribution of these wireframe nucleic acid nanoparticles (NANPs) have not previously been characterized in animal models. In the present study, we observed no indications of toxicity in BALB/c mice following therapeutically relevant dosage of unmodified DNA-based NANPs via intravenous administration, based on liver and kidney histology, liver biochemistry, and body weight. Further, the immunotoxicity of these NANPs was minimal, as indicated by blood cell counts and type-I interferon and pro-inflammatory cytokines. In an SJL/J model of autoimmunity, we observed no indications of NANP-mediated DNA-specific antibody response or immune-mediated kidney pathology following the intraperitoneal administration of NANPs. Finally, biodistribution studies revealed that these NANPs accumulate in the liver within one hour, concomitant with substantial renal clearance. Our observations support the continued development of wireframe DNA-based NANPs as next-generation nucleic acid therapeutic delivery platforms.

• Authors: Eike-Christian Wamhoff, Grant A Knappe, Aurora A Burds, Rebecca R Du, Barry W Neun, Simone Difilippantonio, Chelsea Sanders, Elijah F Edmondson, Jennifer L Matta, Marina A Dobrovolskaia, Mark Bathe
• Journal: bioRxiv : the preprint server for biology (bioRxiv) (Mar 01 2023) United States
• PMID: 36909507 (Publication Type: Preprint)